 |
Journal articles
TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase.
Abstract : One way for intravenous Ig (IVIg) to affect responses of the B cells might be to operate through their TLR7 and TLR9. We confirm the ability of TLR agonists to induce CD25 expression in B cells. For this to occur, sialylated Fc-gamma of IgG included in the IVIg preparation are required. As a result, IVIg suppresses TLR-induced production of the proinflammatory IL-6, but not that of the anti-inflammatory IL-10. That is, IVIg mimics the effects of the MyD88 inhibitor. Finally, as we previously showed that IVIg induces CD22 to recruit the inhibitory SHP-1, we established that this enzyme was also involved in IVIg-induced inhibition of TLR9 signaling. This is the first report to demonstrate such a mechanism underlying the negative impact of IVIg on B lymphocytes.
https://hal.univ-brest.fr/hal-00771231
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Tuesday, January 8, 2013 - 11:28:26 AM
Last modification on : Monday, October 11, 2021 - 2:23:08 PM
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Tuesday, January 8, 2013 - 11:28:26 AM
Last modification on : Monday, October 11, 2021 - 2:23:08 PM